The safety profile of a selective EGFR TKI epitinib (HMPL-813) in patients with advanced solid tumors and preliminary clinical efficacy in EGFRm+ NSCLC patients with brain metastasis
Authors: Qing Zhou, Bin Gan, Liwei Yuan, Ye Hua, Yi-Long Wu
Ba
閱讀更多